Latest Insights

Myricx Pharma Showcases Promising Pre-Clinical Data for NMTi ADC Programme at AACR

Myricx Pharma, an oncology drug discovery company specializing in precision medicines based on its N-myristoyltransferase (NMT) platform, has recently presented …

Continue ›››

Enamine and Endogena's Persistent Collaboration Paves the Way for Regenerative Medicine Advancements

In a world where innovation and collaboration play a critical role in the development of cutting-edge therapies, Enamine Ltd. and …

Continue ›››

Macomics Unveils ENIGMAC™ Discovery Platform at AACR for Target Validation in Macrophage Therapies

Macomics Ltd, a frontrunner in macrophage drug discovery, recently showcased its innovative ENIGMAC™ macrophage drug discovery platform at the American …

Continue ›››

Ultima Genomics and Genome Insight Leverage Artificial Intelligence to Offer Cost-Effective Whole Genome Sequencing for Cancer Patients

Ultima Genomics and Genome Insight have forged a partnership with the objective of providing cost-effective whole genome sequencing solutions to …

Continue ›››

FDA Collaborates with Cerner Enviza and John Snow Labs to Harness AI and EHR Data Analytics for Pharmacovigilance

Cerner Enviza, an Oracle company, and John Snow Labs have been selected by the FDA's Sentinel Innovation Center to support …

Continue ›››

PsychoGenics Introduces eCube, an AI-Driven Platform for Drug Discovery in Neuropsychiatric Disorders

PsychoGenics, a prominent player in AI-enabled phenotypic drug discovery and preclinical CRO services, has recently unveiled eCube, an innovative pharmaco-electroencephalography …

Continue ›››

Some Drugs That Improve Price Competition Fall Through The Cracks Of FDA User Fees

Americans are increasingly concerned about rising drug prices. FDA user fees affect drug pricing competition, which is often overlooked. FDA …

Continue ›››

ConcertAI Unveils Next-Generation Clinical Trial Optimization Platform, CTO 2.0

ConcertAI, an AI Software-as-a-Service (SaaS) and Real-World Evidence (RWE) solutions provider for the life sciences and healthcare sectors, recently announced …

Continue ›››

Introducing “Lab-on-a-Molecule” Drug Discovery Approach via DNA Nanoswitches

The challenge faced by current compound screening approaches often lies in their limitations, either in throughput or their capacity to …

Continue ›››

Introducing PathExplore, a Game-Changing AI Tool for In-Depth Tumor Microenvironment Exploration

As we continue to make progress in oncology therapeutics, researchers are constantly seeking ways to improve patient outcomes by understanding …

Continue ›››

The Emergence of Diffusion Generative Models in Accelerating AI Drug Discovery

Recently, diffusion generative models, such as DALL-E 2 and Midjourney, have attracted considerable interest for their ability to create captivating …

Continue ›››

Advancements in Lipid Nanoparticles for Targeted Gene Therapy in the Lungs

Researchers from MIT and the University of Massachusetts Medical School have developed a new type of lipid nanoparticle designed to …

Continue ›››